Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota

Completed · Not applicable

Conditions studied: Changes in the Oral Microbiota

In brief

Oropharyngeal administration of mother's colostrum to premature infants has been proposed as a stimulus to the oropharyngeal lymphatic tissues to decrease the incidence of pneumonia and sepsis, particularly in intubated babies. We propose to study the impact of this intervention on the composition of the oral microbiota.

Key facts

Study ID

NCT02306980

Run by

University of California, Davis

People needed

12

Starts

2013-10-01

Expected to finish

2016-06-01

Last updated by the study team

2017-07-25

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• premature infant with birth weight < 1500
• intubated in the first 48 hours of life
• available maternal colostrum

You may not qualify if…

• lethal condition

Where it is running

• UC Davis Children's Hospital — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.